Your session is about to expire
What is Utibron
GlycopyrroniumThe Generic name of this drug
Treatment SummaryIndacaterol is a medication used to treat asthma and chronic obstructive pulmonary disease (COPD). It is taken once a day and acts quickly to open up the airways. Indacaterol is sold in Europe under the brand name Onbrez and in the United States under the brand name Arcapta Neohaler. This medication is provided in its maleate salt form, with only the pure R-enantiomer being dispensed.
Robinulis the brand name
Utibron Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Robinul
Glycopyrronium
1961
294
Effectiveness
How Utibron Affects PatientsBronchodilator drugs help open up the airways for people with chronic obstructive pulmonary disease. Indacaterol is a long-lasting bronchodilator that can be taken just once a day. It is 35% more effective than salmeterol, the most common bronchodilator. The most common side effect of indacaterol is a short-lasting cough that usually begins 15 seconds after taking the drug and goes away after 6 seconds. This cough does not cause any other problems, and is no more severe than other bronchodilators.
How Utibron works in the bodyIndacaterol helps to relax and open the airways in asthma and COPD. This is done by stimulating receptors in the smooth muscle of the airways which cause them to relax. Indacaterol binds very strongly to these receptors, allowing it to work quickly and for a long time. It also increases concentrations of cyclic AMP, which helps relax the airways even further. Indacaterol is more active on beta2-receptors compared to beta1- and beta3-receptors, making it more effective at relaxing the airways.
When to interrupt dosage
The recommended dose of Utibron is based on the established condition, including Chronic Obstructive Pulmonary Disease (COPD), Maintenances and symptoms poorly managed by inhaled corticosteroids. The amount of dosage fluctuates, depending on the technique of delivery outlined in the accompanying table.Condition
Dosage
Administration
Oral cavity
, 1.0 mg, 2.0 mg, 0.2 mg/mL, 1.5 mg, 0.05 mg, 0.044 mg, 0.32 mg/mL, 1.0 mg/mL, 0.009 mg, 0.4 mg/mL, 0.0156 mg, 0.025 mg/mL, 0.024 mg/mg, 0.5 mg/mL, 0.0072 mg, 0.043 mg, 0.046 mg, 0.0083 mg/pump actuation, 0.0082 mg/pump actuation, 1.7 mg
, Tablet, Oral, Tablet - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Solution, Solution - Oral, Liquid - Oral, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Solution - Respiratory (inhalation), Solution - Intramuscular; Intravenous, Cloth, Cloth - Topical, Topical, Injection, solution - Intramuscular; Intravitreal, Intramuscular; Intravitreal, Aerosol, Aerosol - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
cardiac vagal inhibitory reflexes
, 1.0 mg, 2.0 mg, 0.2 mg/mL, 1.5 mg, 0.05 mg, 0.044 mg, 0.32 mg/mL, 1.0 mg/mL, 0.009 mg, 0.4 mg/mL, 0.0156 mg, 0.025 mg/mL, 0.024 mg/mg, 0.5 mg/mL, 0.0072 mg, 0.043 mg, 0.046 mg, 0.0083 mg/pump actuation, 0.0082 mg/pump actuation, 1.7 mg
, Tablet, Oral, Tablet - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Solution, Solution - Oral, Liquid - Oral, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Solution - Respiratory (inhalation), Solution - Intramuscular; Intravenous, Cloth, Cloth - Topical, Topical, Injection, solution - Intramuscular; Intravitreal, Intramuscular; Intravitreal, Aerosol, Aerosol - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
Bodily secretions
, 1.0 mg, 2.0 mg, 0.2 mg/mL, 1.5 mg, 0.05 mg, 0.044 mg, 0.32 mg/mL, 1.0 mg/mL, 0.009 mg, 0.4 mg/mL, 0.0156 mg, 0.025 mg/mL, 0.024 mg/mg, 0.5 mg/mL, 0.0072 mg, 0.043 mg, 0.046 mg, 0.0083 mg/pump actuation, 0.0082 mg/pump actuation, 1.7 mg
, Tablet, Oral, Tablet - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Solution, Solution - Oral, Liquid - Oral, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Solution - Respiratory (inhalation), Solution - Intramuscular; Intravenous, Cloth, Cloth - Topical, Topical, Injection, solution - Intramuscular; Intravitreal, Intramuscular; Intravitreal, Aerosol, Aerosol - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
Reflex, Trigeminocardiac
, 1.0 mg, 2.0 mg, 0.2 mg/mL, 1.5 mg, 0.05 mg, 0.044 mg, 0.32 mg/mL, 1.0 mg/mL, 0.009 mg, 0.4 mg/mL, 0.0156 mg, 0.025 mg/mL, 0.024 mg/mg, 0.5 mg/mL, 0.0072 mg, 0.043 mg, 0.046 mg, 0.0083 mg/pump actuation, 0.0082 mg/pump actuation, 1.7 mg
, Tablet, Oral, Tablet - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Solution, Solution - Oral, Liquid - Oral, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Solution - Respiratory (inhalation), Solution - Intramuscular; Intravenous, Cloth, Cloth - Topical, Topical, Injection, solution - Intramuscular; Intravitreal, Intramuscular; Intravitreal, Aerosol, Aerosol - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
Hyperhidrosis disorder
, 1.0 mg, 2.0 mg, 0.2 mg/mL, 1.5 mg, 0.05 mg, 0.044 mg, 0.32 mg/mL, 1.0 mg/mL, 0.009 mg, 0.4 mg/mL, 0.0156 mg, 0.025 mg/mL, 0.024 mg/mg, 0.5 mg/mL, 0.0072 mg, 0.043 mg, 0.046 mg, 0.0083 mg/pump actuation, 0.0082 mg/pump actuation, 1.7 mg
, Tablet, Oral, Tablet - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Solution, Solution - Oral, Liquid - Oral, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Solution - Respiratory (inhalation), Solution - Intramuscular; Intravenous, Cloth, Cloth - Topical, Topical, Injection, solution - Intramuscular; Intravitreal, Intramuscular; Intravitreal, Aerosol, Aerosol - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
Reflex, Trigeminocardiac
, 1.0 mg, 2.0 mg, 0.2 mg/mL, 1.5 mg, 0.05 mg, 0.044 mg, 0.32 mg/mL, 1.0 mg/mL, 0.009 mg, 0.4 mg/mL, 0.0156 mg, 0.025 mg/mL, 0.024 mg/mg, 0.5 mg/mL, 0.0072 mg, 0.043 mg, 0.046 mg, 0.0083 mg/pump actuation, 0.0082 mg/pump actuation, 1.7 mg
, Tablet, Oral, Tablet - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Solution, Solution - Oral, Liquid - Oral, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Solution - Respiratory (inhalation), Solution - Intramuscular; Intravenous, Cloth, Cloth - Topical, Topical, Injection, solution - Intramuscular; Intravitreal, Intramuscular; Intravitreal, Aerosol, Aerosol - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
Induction of anesthesia therapy
, 1.0 mg, 2.0 mg, 0.2 mg/mL, 1.5 mg, 0.05 mg, 0.044 mg, 0.32 mg/mL, 1.0 mg/mL, 0.009 mg, 0.4 mg/mL, 0.0156 mg, 0.025 mg/mL, 0.024 mg/mg, 0.5 mg/mL, 0.0072 mg, 0.043 mg, 0.046 mg, 0.0083 mg/pump actuation, 0.0082 mg/pump actuation, 1.7 mg
, Tablet, Oral, Tablet - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Solution, Solution - Oral, Liquid - Oral, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Solution - Respiratory (inhalation), Solution - Intramuscular; Intravenous, Cloth, Cloth - Topical, Topical, Injection, solution - Intramuscular; Intravitreal, Intramuscular; Intravitreal, Aerosol, Aerosol - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
peripheral muscarinic effects
, 1.0 mg, 2.0 mg, 0.2 mg/mL, 1.5 mg, 0.05 mg, 0.044 mg, 0.32 mg/mL, 1.0 mg/mL, 0.009 mg, 0.4 mg/mL, 0.0156 mg, 0.025 mg/mL, 0.024 mg/mg, 0.5 mg/mL, 0.0072 mg, 0.043 mg, 0.046 mg, 0.0083 mg/pump actuation, 0.0082 mg/pump actuation, 1.7 mg
, Tablet, Oral, Tablet - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Solution, Solution - Oral, Liquid - Oral, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Solution - Respiratory (inhalation), Solution - Intramuscular; Intravenous, Cloth, Cloth - Topical, Topical, Injection, solution - Intramuscular; Intravitreal, Intramuscular; Intravitreal, Aerosol, Aerosol - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
Peptic Ulcer
, 1.0 mg, 2.0 mg, 0.2 mg/mL, 1.5 mg, 0.05 mg, 0.044 mg, 0.32 mg/mL, 1.0 mg/mL, 0.009 mg, 0.4 mg/mL, 0.0156 mg, 0.025 mg/mL, 0.024 mg/mg, 0.5 mg/mL, 0.0072 mg, 0.043 mg, 0.046 mg, 0.0083 mg/pump actuation, 0.0082 mg/pump actuation, 1.7 mg
, Tablet, Oral, Tablet - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Solution, Solution - Oral, Liquid - Oral, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Solution - Respiratory (inhalation), Solution - Intramuscular; Intravenous, Cloth, Cloth - Topical, Topical, Injection, solution - Intramuscular; Intravitreal, Intramuscular; Intravitreal, Aerosol, Aerosol - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
Drooling
, 1.0 mg, 2.0 mg, 0.2 mg/mL, 1.5 mg, 0.05 mg, 0.044 mg, 0.32 mg/mL, 1.0 mg/mL, 0.009 mg, 0.4 mg/mL, 0.0156 mg, 0.025 mg/mL, 0.024 mg/mg, 0.5 mg/mL, 0.0072 mg, 0.043 mg, 0.046 mg, 0.0083 mg/pump actuation, 0.0082 mg/pump actuation, 1.7 mg
, Tablet, Oral, Tablet - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Solution, Solution - Oral, Liquid - Oral, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Solution - Respiratory (inhalation), Solution - Intramuscular; Intravenous, Cloth, Cloth - Topical, Topical, Injection, solution - Intramuscular; Intravitreal, Intramuscular; Intravitreal, Aerosol, Aerosol - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
Increased upper airway secretion
, 1.0 mg, 2.0 mg, 0.2 mg/mL, 1.5 mg, 0.05 mg, 0.044 mg, 0.32 mg/mL, 1.0 mg/mL, 0.009 mg, 0.4 mg/mL, 0.0156 mg, 0.025 mg/mL, 0.024 mg/mg, 0.5 mg/mL, 0.0072 mg, 0.043 mg, 0.046 mg, 0.0083 mg/pump actuation, 0.0082 mg/pump actuation, 1.7 mg
, Tablet, Oral, Tablet - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Solution, Solution - Oral, Liquid - Oral, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Solution - Respiratory (inhalation), Solution - Intramuscular; Intravenous, Cloth, Cloth - Topical, Topical, Injection, solution - Intramuscular; Intravitreal, Intramuscular; Intravitreal, Aerosol, Aerosol - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
Emphysema
, 1.0 mg, 2.0 mg, 0.2 mg/mL, 1.5 mg, 0.05 mg, 0.044 mg, 0.32 mg/mL, 1.0 mg/mL, 0.009 mg, 0.4 mg/mL, 0.0156 mg, 0.025 mg/mL, 0.024 mg/mg, 0.5 mg/mL, 0.0072 mg, 0.043 mg, 0.046 mg, 0.0083 mg/pump actuation, 0.0082 mg/pump actuation, 1.7 mg
, Tablet, Oral, Tablet - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Solution, Solution - Oral, Liquid - Oral, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Solution - Respiratory (inhalation), Solution - Intramuscular; Intravenous, Cloth, Cloth - Topical, Topical, Injection, solution - Intramuscular; Intravitreal, Intramuscular; Intravitreal, Aerosol, Aerosol - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
Chronic Obstructive Pulmonary Disease
, 1.0 mg, 2.0 mg, 0.2 mg/mL, 1.5 mg, 0.05 mg, 0.044 mg, 0.32 mg/mL, 1.0 mg/mL, 0.009 mg, 0.4 mg/mL, 0.0156 mg, 0.025 mg/mL, 0.024 mg/mg, 0.5 mg/mL, 0.0072 mg, 0.043 mg, 0.046 mg, 0.0083 mg/pump actuation, 0.0082 mg/pump actuation, 1.7 mg
, Tablet, Oral, Tablet - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Solution, Solution - Oral, Liquid - Oral, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Solution - Respiratory (inhalation), Solution - Intramuscular; Intravenous, Cloth, Cloth - Topical, Topical, Injection, solution - Intramuscular; Intravitreal, Intramuscular; Intravitreal, Aerosol, Aerosol - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
Choking
, 1.0 mg, 2.0 mg, 0.2 mg/mL, 1.5 mg, 0.05 mg, 0.044 mg, 0.32 mg/mL, 1.0 mg/mL, 0.009 mg, 0.4 mg/mL, 0.0156 mg, 0.025 mg/mL, 0.024 mg/mg, 0.5 mg/mL, 0.0072 mg, 0.043 mg, 0.046 mg, 0.0083 mg/pump actuation, 0.0082 mg/pump actuation, 1.7 mg
, Tablet, Oral, Tablet - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Solution, Solution - Oral, Liquid - Oral, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Solution - Respiratory (inhalation), Solution - Intramuscular; Intravenous, Cloth, Cloth - Topical, Topical, Injection, solution - Intramuscular; Intravitreal, Intramuscular; Intravitreal, Aerosol, Aerosol - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
Neurological Conditions
, 1.0 mg, 2.0 mg, 0.2 mg/mL, 1.5 mg, 0.05 mg, 0.044 mg, 0.32 mg/mL, 1.0 mg/mL, 0.009 mg, 0.4 mg/mL, 0.0156 mg, 0.025 mg/mL, 0.024 mg/mg, 0.5 mg/mL, 0.0072 mg, 0.043 mg, 0.046 mg, 0.0083 mg/pump actuation, 0.0082 mg/pump actuation, 1.7 mg
, Tablet, Oral, Tablet - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Solution, Solution - Oral, Liquid - Oral, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Solution - Respiratory (inhalation), Solution - Intramuscular; Intravenous, Cloth, Cloth - Topical, Topical, Injection, solution - Intramuscular; Intravitreal, Intramuscular; Intravitreal, Aerosol, Aerosol - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
Chronic Bronchitis
, 1.0 mg, 2.0 mg, 0.2 mg/mL, 1.5 mg, 0.05 mg, 0.044 mg, 0.32 mg/mL, 1.0 mg/mL, 0.009 mg, 0.4 mg/mL, 0.0156 mg, 0.025 mg/mL, 0.024 mg/mg, 0.5 mg/mL, 0.0072 mg, 0.043 mg, 0.046 mg, 0.0083 mg/pump actuation, 0.0082 mg/pump actuation, 1.7 mg
, Tablet, Oral, Tablet - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Solution, Solution - Oral, Liquid - Oral, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Solution - Respiratory (inhalation), Solution - Intramuscular; Intravenous, Cloth, Cloth - Topical, Topical, Injection, solution - Intramuscular; Intravitreal, Intramuscular; Intravitreal, Aerosol, Aerosol - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
General Surgery
, 1.0 mg, 2.0 mg, 0.2 mg/mL, 1.5 mg, 0.05 mg, 0.044 mg, 0.32 mg/mL, 1.0 mg/mL, 0.009 mg, 0.4 mg/mL, 0.0156 mg, 0.025 mg/mL, 0.024 mg/mg, 0.5 mg/mL, 0.0072 mg, 0.043 mg, 0.046 mg, 0.0083 mg/pump actuation, 0.0082 mg/pump actuation, 1.7 mg
, Tablet, Oral, Tablet - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Solution, Solution - Oral, Liquid - Oral, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Solution - Respiratory (inhalation), Solution - Intramuscular; Intravenous, Cloth, Cloth - Topical, Topical, Injection, solution - Intramuscular; Intravitreal, Intramuscular; Intravitreal, Aerosol, Aerosol - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
Cerebral Palsy
, 1.0 mg, 2.0 mg, 0.2 mg/mL, 1.5 mg, 0.05 mg, 0.044 mg, 0.32 mg/mL, 1.0 mg/mL, 0.009 mg, 0.4 mg/mL, 0.0156 mg, 0.025 mg/mL, 0.024 mg/mg, 0.5 mg/mL, 0.0072 mg, 0.043 mg, 0.046 mg, 0.0083 mg/pump actuation, 0.0082 mg/pump actuation, 1.7 mg
, Tablet, Oral, Tablet - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Solution, Solution - Oral, Liquid - Oral, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Solution - Respiratory (inhalation), Solution - Intramuscular; Intravenous, Cloth, Cloth - Topical, Topical, Injection, solution - Intramuscular; Intravitreal, Intramuscular; Intravitreal, Aerosol, Aerosol - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
Rapid Anticholinergic Effect Desired
, 1.0 mg, 2.0 mg, 0.2 mg/mL, 1.5 mg, 0.05 mg, 0.044 mg, 0.32 mg/mL, 1.0 mg/mL, 0.009 mg, 0.4 mg/mL, 0.0156 mg, 0.025 mg/mL, 0.024 mg/mg, 0.5 mg/mL, 0.0072 mg, 0.043 mg, 0.046 mg, 0.0083 mg/pump actuation, 0.0082 mg/pump actuation, 1.7 mg
, Tablet, Oral, Tablet - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Solution, Solution - Oral, Liquid - Oral, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Solution - Respiratory (inhalation), Solution - Intramuscular; Intravenous, Cloth, Cloth - Topical, Topical, Injection, solution - Intramuscular; Intravitreal, Intramuscular; Intravitreal, Aerosol, Aerosol - Respiratory (inhalation), Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
Warnings
Utibron ContraindicationsCondition
Risk Level
Notes
Ulcerative Colitis
Do Not Combine
Uterine Inertia
Do Not Combine
Ulcerative Colitis
Do Not Combine
Myasthenia Gravis
Do Not Combine
Arterial Occlusive Diseases
Do Not Combine
Cardiovascular Physiological Phenomena
Do Not Combine
Pulse Frequency
Do Not Combine
Therapeutic procedure
Do Not Combine
Paralytic Ileus
Do Not Combine
Open-angle glaucoma
Do Not Combine
Uropathy Obstructive
Do Not Combine
Severe Hypersensitivity Reactions
Do Not Combine
Glycopyrronium may interact with Pulse Frequency
Common Utibron Drug Interactions
Drug Name
Risk Level
Description
Aclidinium
Major
The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Aclidinium.
Cimetropium
Major
The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Cimetropium.
Eluxadoline
Major
The risk or severity of constipation can be increased when Glycopyrronium is combined with Eluxadoline.
Macimorelin
Major
The therapeutic efficacy of Macimorelin can be decreased when used in combination with Glycopyrronium.
Secretin human
Major
The therapeutic efficacy of Secretin human can be decreased when used in combination with Glycopyrronium.
Utibron Toxicity & Overdose RiskTaking too much indacaterol may cause symptoms like chest pain, high or low blood pressure, rapid heartbeat, anxiety, headache, shaking, thirst, palpitations, muscle cramps, nausea, dizziness, tiredness, feeling unwell, low potassium levels, high blood sugar, metabolic acidosis, and difficulty sleeping. In severe cases, it can lead to cardiac arrest and death.
Utibron Novel Uses: Which Conditions Have a Clinical Trial Featuring Utibron?
243 active trials are being conducted to assess the utility of Utibron in treating Asthma symptoms inadequately controlled with inhaled corticosteroids as well as Chronic Obstructive Pulmonary Disease (COPD).Condition
Clinical Trials
Trial Phases
Oral cavity
0 Actively Recruiting
Rapid Anticholinergic Effect Desired
0 Actively Recruiting
Reflex, Trigeminocardiac
0 Actively Recruiting
Reflex, Trigeminocardiac
0 Actively Recruiting
Emphysema
12 Actively Recruiting
Phase 3, Phase 4, Phase 1, Phase 2, Not Applicable
peripheral muscarinic effects
0 Actively Recruiting
Chronic Bronchitis
5 Actively Recruiting
Not Applicable, Phase 3, Phase 4
Induction of anesthesia therapy
0 Actively Recruiting
Drooling
1 Actively Recruiting
Early Phase 1
Hyperhidrosis disorder
0 Actively Recruiting
Neurological Conditions
0 Actively Recruiting
Cerebral Palsy
1 Actively Recruiting
Not Applicable
Increased upper airway secretion
0 Actively Recruiting
cardiac vagal inhibitory reflexes
0 Actively Recruiting
Chronic Obstructive Pulmonary Disease
100 Actively Recruiting
Phase 3, Not Applicable, Phase 1, Phase 2, Early Phase 1, Phase 4
Bodily secretions
0 Actively Recruiting
Choking
13 Actively Recruiting
Not Applicable, Phase 3, Phase 2, Phase 1
Peptic Ulcer
2 Actively Recruiting
Not Applicable, Phase 4
General Surgery
1 Actively Recruiting
Not Applicable
Utibron Reviews: What are patients saying about Utibron?
5Patient Review
5/27/2019 This is by far the best medication I have ever used. There are hardly any side effects and I don't have to use my rescue inhaler as much.
5Patient Review
11/18/2018 Utibron has been a revelation for me. I'm breathing better and have more energy than I have in months.
4Patient Review
9/16/2016Patient Q&A Section about utibron
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.What is Bevespi prescribed for?
"This medicine is for use in adults 18 years of age and older.
Bevsepi Aerosphere is a prescription medicine used to treat chronic obstructive pulmonary disease (COPD). COPD includes chronic bronchitis, emphysema, or both. Bevsepi Aerosphere is used as 2 inhalations, 2 times each day in the morning and in the evening, to improve symptoms of COPD for better breathing.
This medicine is for use in adults 18 years of age and older."
Answered by AI
What is Utibron neohaler?
"USING UTIBRON NEOHALER
UTIBRON NEOHALER is indicated for the long-term, maintenance treatment of airflow obstruction in patients with COPD, including chronic bronchitis and/or emphysema. The recommended dose is 75 mcg of indacaterol and 21 mcg of glycopyrrolate inhaled once daily.
Patients should use UTIBRON NEOHALER at the same time each day. UTIBRON NEOHALER can be used with or without food."
Answered by AI
Who makes Utibron?
"Sunovion is committed to expanding its heritage of advancing new treatments for serious respiratory medical conditions, including the 15.7 million people in the U.S. who suffer from COPD."
Answered by AI
What is UTIBRON?
"Utibron Neohaler is a prescription medicine used to treat the symptoms of Chronic Obstructive Pulmonary Disease (COPD). Utibron Neohaler is typically used in conjunction with other medications."
Answered by AI